|
 |
::: |
 |
I. |
Authorization
Method & Scope |
|
In order to
facilitate the public to better utilize the website
information, all of Kaohsiung Municipal Kai-Syuan
Psychiatric Hospital publicly posted information and
materials that are protected under copyright provisions may
be reauthorized for public use without cost in a
non-exclusive manner. The users are not limited to time and
by region to reproduce, adapt, edit, publicly transmit or
utilize with other methods, and as well as to develop
various products or services (herein known as derivations).
This authorization will not be retracted hereafter, and the
users do not have to acquire any written or other methods of
authorization from the Administration. However, when using
it, the user should state the source. |
II. |
Information on
Related Items: |
|
(a) |
The
authorized scope is only within the scope protected
under copyright. It does not include other
intellectual property rights, including but not
limited to the provision of patents, trademarks and
administration’s logo. |
(b) |
Whether
or not the said person’s actively publicized or
legally required publicized personal information can
be collected, processed or utilized, the user must
follow the related provisions based on the Personal
Information Protection Act, and plan to execute the
related measures required by law. |
(c) |
For
some videos, photos, sheet music and contracted case
writings or other works, the administration must
especially state that the approval must be duly
obtained before use. |
|
III. |
Should be
prudential not to infringe upon a third party in moral
rights in copyrights (including the rights to identify names
and the rights to ban unjustifiable change.) |
IV. |
After using the
information and material provided by this authorization, one
should not maliciously alter its related information. If
edited and the reworked information does not match the
original, the user is liable for civil and criminal legal
responsibilities. |
V. |
The website’s
authorization does not authorize the user to represent the
administration’s recommendation, approval or agreement with
the status of the added derivatives. |
|
 |
updated 2015.10.21 |
|
|
|
 |
|
|